- Posted
- Categories
-
- OpenPrescribing Hospitals
OpenPrescribing Hospitals: numbers please!
A look at how to use the summary tables produced in custom analyses on OpenPrescribing Hospitals.
Latest news and views from around the Bennett Institute
A look at how to use the summary tables produced in custom analyses on OpenPrescribing Hospitals.
In this guest blog James Galloway a Professor of Rheumatology and an Honorary Consultant Rheumatologist in South London, at King’s College London describes how his team used OpenPrescribing to reduce unsafe methotrexate prescribing and shares his thoughts on improving quality of care may deliver most improvements for the populations health.
We are looking for people to be part of a new Experience-led Public Advisory Group that will meet regularly to advise and guide the development phases of the OpenSAFELY-Talking Therapies programme.
How you can run custom analyses of variation in medicines issuing across NHS trusts, ICB, region and nationally.
A summary of our research letter highlighting continuing co-proxamol use, published in the British Journal of General Practice
Come and work with us! We’re looking for Epidemiologists / Health Data Scientists to join our growing research team.
A national medicines usage analysis for lithium in primary and secondary care in England
We’ve launched a new OpenPrescribing Hospitals ‘low value prescribing’ measure for lidocaine plasters.
This blog post shares the project I worked on during my summer internship at the Bennett Institute as part of the HDR UK Health Data Science programme. My project explored how ehrQL, is being used across OpenSAFELY repositories. I analysed 301 codefiles from 65 Repositories under the OpenSafely org. and was able to identified which features researchers rely on most, which are less common, and where improvements or additional support could be valuable.
Special edition OpenPrescribing newsletter introducing our new tool, OpenPrescribing Hospitals.
We’re launching the Bennett Prize in OpenPrescribing to celebrate the best user-led projects using OpenPrescribing. Enter by sharing your work online and sending us the link — all kinds of entries welcome, from prescribing insights to data science deep dives.
We are starting a UKRI-funded project on improving code sharing and want your help!
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?
In this guest blog, Dr Christianne Micallef explains how she uses OpenPrescribing in her role as an antimicrobial stewardship lead pharmacist.
A look at the new Product Lookup feature on OpenPrescribing Hospitals
What is a Defined Daily Dose, how can they calculated from the quantity reported in the Secondary Care Medicines Data, and why are they useful?
How the ATC can be used to classify medications and how DDs can be used to measure their usage.
The journey of public involvement in OpenSAFELY. The OpenSAFELY Digital Critical Friend group, from conception to becoming foundational for OpenSAFELY, is a testament to the power of effective public involvement in digital health.